Literature DB >> 26599102

Anti- C N1A antibodies in South Australian patients with inclusion body myositis.

Vidya S Limaye1, Sue Lester2, Peter Blumbergs3, Steven A Greenberg4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26599102     DOI： 10.1002/mus.24989

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN： 0148-639X            Impact factor:   3.217


× No keyword cloud information.
  10 in total

1.  Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis.

Authors:  Richard M Yeker; Iago Pinal-Fernandez; Lisa G Rider; Andrew L Mammen; Takayuki Kishi; Katherine Pak; Ira N Targoff; Frederick W Miller
Journal:  Ann Rheum Dis       Date:  2018-01-23       Impact factor: 19.103

Review 2.  New Developments in the Genetics of Inclusion Body Myositis.

Authors:  Kyla A Britson; Stephanie Y Yang; Thomas E Lloyd
Journal:  Curr Rheumatol Rep       Date:  2018-04-02       Impact factor: 4.592

3.  Geographical Latitude Remains as an Important Factor for the Prevalence of Some Myositis Autoantibodies: A Systematic Review.

Authors:  Andrea Aguilar-Vazquez; Efrain Chavarria-Avila; Oscar Pizano-Martinez; Alejandra Ramos-Hernandez; Lilia Andrade-Ortega; Edy-David Rubio-Arellano; Monica Vazquez-Del Mercado
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

Review 4.  Genetics in inclusion body myositis.

Authors:  Simon Rothwell; James B Lilleker; Janine A Lamb
Journal:  Curr Opin Rheumatol       Date:  2017-11       Impact factor: 5.006

5.  Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum.

Authors:  Simon Rothwell; Robert G Cooper; Ingrid E Lundberg; Peter K Gregersen; Michael G Hanna; Pedro M Machado; Megan K Herbert; Ger J M Pruijn; James B Lilleker; Mark Roberts; John Bowes; Michael F Seldin; Jiri Vencovsky; Katalin Danko; Vidya Limaye; Albert Selva-O'Callaghan; Hazel Platt; Øyvind Molberg; Olivier Benveniste; Timothy R D J Radstake; Andrea Doria; Jan De Bleecker; Boel De Paepe; Christian Gieger; Thomas Meitinger; Juliane Winkelmann; Christopher I Amos; William E Ollier; Leonid Padyukov; Annette T Lee; Janine A Lamb; Hector Chinoy
Journal:  Arthritis Rheumatol       Date:  2017-04-04       Impact factor: 10.995

6.  Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis.

Authors:  J B Lilleker; A Rietveld; S R Pye; K Mariampillai; O Benveniste; M T J Peeters; J A L Miller; M G Hanna; P M Machado; M J Parton; K R Gheorghe; U A Badrising; I E Lundberg; S Sacconi; M K Herbert; N J McHugh; B R F Lecky; C Brierley; D Hilton-Jones; J A Lamb; M E Roberts; R G Cooper; C G J Saris; G J M Pruijn; H Chinoy; B G M van Engelen
Journal:  Ann Rheum Dis       Date:  2017-01-25       Impact factor: 19.103

Review 7.  Immune and myodegenerative pathomechanisms in inclusion body myositis.

Authors:  Christian W Keller; Jens Schmidt; Jan D Lünemann
Journal:  Ann Clin Transl Neurol       Date:  2017-05-16       Impact factor: 4.511

8.  Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.

Authors:  Anke Rietveld; Luuk L van den Hoogen; Nicola Bizzaro; Sofie L M Blokland; Cornelia Dähnrich; Jacques-Eric Gottenberg; Gunnar Houen; Nora Johannsen; Thomas Mandl; Alain Meyer; Christoffer T Nielsen; Peter Olsson; Joel van Roon; Wolfgang Schlumberger; Baziel G M van Engelen; Christiaan G J Saris; Ger J M Pruijn
Journal:  Front Immunol       Date:  2018-06-05       Impact factor: 7.561

9.  Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis.

Authors:  Matteo Lucchini; Lorenzo Maggi; Elena Pegoraro; Massimiliano Filosto; Carmelo Rodolico; Giovanni Antonini; Matteo Garibaldi; Maria Lucia Valentino; Gabriele Siciliano; Giorgio Tasca; Valeria De Arcangelis; Chiara De Fino; Massimiliano Mirabella
Journal:  Cells       Date:  2021-05-10       Impact factor: 6.600

Review 10.  New insights into the treatment of myositis.

Authors:  Stefanie Glaubitz; Rachel Zeng; Jens Schmidt
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-01-08       Impact factor: 5.346
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.